Sotsiaalministeerium · 27. september 2018
Sisu (failidest)
Ministerial policy dialogue on HIV and
related comorbidities in eastern Europe and
central Asia (EECA)1
Mövenpick Hotel Amsterdam City Centre
Amsterdam, 23 July 2018
Original: English
Meeting Report
1
EECA Member States of the WHO European Region: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania,
Republic of Moldova, Russian Federation, Tajikistan, Turkmenistan, Uzbekistan and Ukraine.
Abbreviations
AIDS Acquired immune deficiency syndrome
CSO Civil society organization
EECA eastern Europe and central Asia
GFATM Global Fund to Fight AIDS, Tuberculosis and Malaria
HIV Human immunodeficiency virus
NGO Non-governmental organization
UNAIDS Joint United Nations Programme on HIV/AIDS
UNFPA United Nations Population Fund
UNICEF United Nations Children’s Fund
WHO World Health Organization
MSM Men who have sex with men
PREP pre-exposure prophylactic treatment
SRHR sexual reproductive health and rights
PEP post-exposure prophylactic treatment
INTRODUCTION
Background
Mr James Chau (United Nations Goodwill Ambassador) opened the meeting by noting the unique design of the
closed-door framework and welcomed the presence of all ten honourable Minister and Deputy Ministers. Mr Chau
focused on the meeting as a unique platform where Ministers may learn from each other before moving to to an
overview of Regional epidemiology.
Ministers of Health unanimously endorsed the Action plan for the health sector response to HIV in the WHO European
Region during the 66th session of the Regional Committee for Europe in September 2016, thereby expressing enhanced
commitment to scale-up response efforts to the growing HIV epidemic. Member States, key partners, including civil
society groups, communities of people living with HIV and donors agreed to reach key 90-90-90 targets2 by 2020
through evidence based HIV prevention, accessible and affordable testing, treatment and care services to end AIDS by
as a public health threat by 2030 in accordance with Sustainable Development Goal 3.3
On 25 and 26 September 2017, the WHO Regional Office for Europe, in collaboration with UNAIDS, convened a
meeting of HIV programme managers, at which representatives of EECA countries and Member States not members of
the European Union or European Economic Area presented the status of their national HIV strategies and action plans.
Countries reported national efforts to revise and optimize their HIV testing and treatment policies. Several countries
have started the “treat all”3 approach and others have endorsed new national HIV testing and treatment protocols and/or
implemented nationwide innovative interventions, such as self-testing. Building on the lessons learned from successful
interventions and programmes, there is an urgent need to scale up effective preventive measures, early diagnosis and
quality treatment and integrated/coordinated care for all, with a specific focus on key populations, to curb the epidemic.
Several countries in the EECA part of the Region are transitioning from international donor funding towards domestic
funding of the HIV response. Finding innovative and inclusive mechanisms for financing the HIV response in this
context is a pressing topic.
Ministerial policy dialogue on HIV and related co-morbidities in eastern Europe and central Asia
Partnership: the meeting was jointly organized by the WHO Regional Office for Europe, Government of the
Netherlands, and UNAIDS back-to-back with the 22nd International AIDS Conference to bridge further between the
eastern European and central Asian countries where the epidemic continues to rise.
Ministerial Representation: To provide quality and timely people-centred services and curb the epidemic, there is a
need for strong political will, adequate funding and exchange of know how to address barriers. To this end, the
Ministers of Health of eastern Europe and central Asia countries were invited to a Ministerial Policy Dialogue4. This is
one of the first times such number of high-level Ministerial delegation was present to share good practices in the health
sector response to HIV in the WHO European Region.
Outline: to compliment the AIDS2018 theme “Breaking Barriers, Building Bridges” and recognizing bridges must
exist between politicians, geographical regions, governments, civil society organizations (CSOs), including
representatives of key populations, the meeting was designed with the following six main components back-to-back
with a Civil Society Dialogue organized by AIDS Foundation East-West5:
(1) Welcome remarks (to review the scope and purpose of the event and urgency of taking actions by all)
(2) Setting the scene [to present people perspective, political dimension and WHO recommendations);
(3) Panel Discussion [to showcase good practices in the response to HIV epidemic on the Ministerial level];
2
By 2020: 90% of all people living with HIV will know their HIV status; 90% of all people diagnosed with HIV infection will receive sustained
antiretroviral therapy; 90% of all people receiving antiretroviral therapy will have viral suppression.
3
Antiretroviral treatment is recommended for all people with confirmed HIV infection, however severely affected their immune system, i.e.
regardless of their CD4 count.
4
See Annex 2 (List of Participants)
5
See Annex 1 (Programme)
(4) Roundtable Discussion [to gather inputs from key partners];
(5) Conclusion (to present the next steps)
(6) Launch of the Compendium of good HIV practices6 [to identify and facilitate the exchange of best practices
and experiences among Member States; and to produce evidence-informed tools for an effective HIV
response];
Aims & Objectives
(1) to present the countries’ pioneering approaches to sustainable, innovative, and evidence-based response to HIV
and related comorbidities and discuss the opportunities to scale these up in line with the resolution
EUR/RC66/R9;
(2) to exchange information on sustainable financing;
(3) to launch the Compendium of good practices for the implementation of the Action plan for the health sector
response to HIV in the WHO European Region;
Outcomes
(1) Good practices on political commitment in response to HIV and related comorbidities are shared among
countries.
(2) A report of the event including conclusions and the next steps is prepared.
Opening Remarks
Mr Lambert Grijns (Ambassador for Sexual and Reproductive Health and Rights & HIV/AIDS, Government of
the Netherlands) opened the meeting expressing the excitement and intention the Government of the Netherlands has
had for more than five years to host the 22nd International AIDS Conference (AIDS2018) proceedings in Amsterdam to
initiate a dialogue on the growing HIV epidemic in Europe, especially with regard to the eastern and central parts of the
Region. Mr Grijns proposed the success of health interventions primarily depend on political leadership, in addition to
technical and financial capacity, underscoring the importance of the Ministers, Deputy Ministers and State Secretaries’
attendance. He cited the examples of the Netherlands successfully eliminating HIV transmission among people who
inject drugs, of which cost savings have been monumental, and thriving for innovative approaches with recently
providing pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM).
The theme is of AIDS2018 was “Breaking Barriers, Building Bridges”. Mr Grijns highlighted that bridges are needed
between all HIV stakeholders including politicians, regions, governments, civil society organizations (CSOs), all HIV
key populations7 and marginalised groups, and the private sector. In addition, the need to engage the private sector
where and when feasible was highlighted.
Dr Zsuzsanna Jakab (Regional Director, WHO Regional Office for Europe) reminded participants the WHO
European Region is the only region worldwide where the number of new HIV infections is rising. For several
consecutive years the Region has recorded the highest-ever number of new cases and the eastern part of the Region
hosts almost 80% of these new HIV infections8. In 2016, more than 160 000 were newly diagnosed with HIV
(corresponding to a rate of 18.2 diagnoses per 100 000 population). In regard to 90-90-90 targets, one quarter of people
living with HIV in eastern Europe and central Asia are not aware of their infection, over half are diagnosed late
resulting in delayed treatment, higher AIDS-related morbidity and mortality, and increased rates of transmission persist
despite availability of the needed diagnostic tools and newly recommended innovations to reduce the undiagnosed
fraction and number of late presenters. However, the WHO European Region had the largest amount of data and
number of Member States reporting since HIV reporting began in the Region. The second target of getting 90% of those
diagnosed with HIV on treatment represents the most significant challenge for the Region. In eastern Europe and central
6
Compendium of good practices in the health sector response to HIV in the WHO European Region
7
In the European Region, key populations include people living with HIV, people who inject drugs, men who have sex with men (MSM),
transgender people, sex workers (SW), prisoners and migrants.
8
Two out of 53 countries accounted for 80% of all new cases in 2016.
Asia, half of those diagnosed with HIV and only one third of the estimated number of people living with HIV have
access to treatment. However, the WHO European Region proudly reports over 95% HIV treatment coverage for
pregnant women9. Regarding viral suppression10, four out of five persons reach viral suppression once they are
diagnosed and on effective treatment11 and recent evidence shows that people who achieve and maintain an
undetectable viral load have no risk of sexually transmitting the virus to an HIV-negative partner. With timely
diagnosis, treatment for all, leading to suppressed viral loads, provided alongside evidence-based combination
prevention, it is possible to halt, reverse, and stop the HIV epidemic in the Region. Examples of good HIV practices
were submitted to WHO by 32 Member States to honour RD’s commitment during the 66th Session of the Regional
Committee for Europe’s resolution “to identify and facilitate the exchange of best practices and experiences among
Member States and to produce evidence-informed tools for an effective HIV response”.
Despite the Region’s slow trajectory to reach 2020 targets, Mr Vinay Saldanha (UNAIDS) called upon stakeholders to
focus on successes responding to the HIV epidemic and discover areas where Member States, Ministers, and health
providers are willing to leverage a cheaper, faster, and more effective HIV response.
Cheaper Rather than spend more financial resources on HIV, Member States were encouraged to spend more
effectively the resources currently available. Allocation needs to be optimised to eliminate
inefficiencies. Examples may include: leveraging reduced unit costs for first line ARV treatment to
make sure they fall under 100 USD12 based on a fixed dose combination recommended by WHO;
performing multi-joint, bulk drug purchases for the most effective medicines; and purchasing the best
diagnostic equipment offers for the lowest cost.
Faster Full integration of HIV and TB services is essential, but HIV needs to be the launchpad for
integration with maternal and child health, viral hepatitis and STIs. The Member States should
consider the effective and impressive role of CSOs which consistently implement highly technical
and cost-effective programmes. Ministries of Health and Governments of the Region view them as
one of the highest priorities for government funding & efficient spending in the eastern European and
central Asian part of the Region. Increasing net HIV investment is important, but the tools to assure
every dollar spent by governments is spent efficiently already exist and are underused.
Effective Political commitment and leadership is evidenced through the Ministerial Delegation present at the
meeting, but even more leaders should be engaged. Mayors and cities in the eastern and central part of
the WHO European Region should be fully engaged and sign the Paris Declaration13 to become Fast-
Track Cities. In addition, leadership through the heads of state are the cornerstone to remove the
epidemic of HIV stigma and discrimination. Although difficult, writing inclusive policy and removing
stigmatising legislation is a cheap and cost-effective way to form partnerships with people living with
HIV.
Setting the Scene
Professor Michel Kazatchkine (Special Advisor for Eastern Europe and Central Asia, UNAIDS), acknowledged
the enormous potential of the EECA countries to end AIDS by 2030. The following improvements in the HIV response
would realise this potential;
Integrate all technical areas & surveillance systems for MDR-TB/TB, HIV, viral hepatitis, and STIs within
all aspects of prevention, testing, treatment, and care;
9
Since 2016, three countries in eastern Europe have validated the elimination of mother-to-child transmission of HIV and syphilis, and others may
soon qualify for this same milestone.
10
Full achievement of 90–90–90 is equal to viral load suppression among 73% of all people living with HIV.
11
Virological failure: viral load above 1,000 copies/ml based on two consecutive viral load measurements in a 3-month interval, with adherence
support following the first viral load test, after at least six months of starting a new ART regimen.
12
per person per year
13
On World AIDS Day 2014, mayors from around the world came together in Paris, France, to sign a declaration to end the AIDS epidemic in their
cities. In signing the 2014 Paris Declaration, the mayors commit to putting cities on the Fast-Track to ending the AIDS epidemic through a set of
commitments.
Harness efforts to obtain better data and real time evidence on the epidemics to better align strategies to the
specific epidemiological contexts in which they occur;
Scale-up access to treatment and life-saving, evidence-based prevention interventions [referencing the
upcoming Alma Ata conference Global Conference on Primary Healthcare, 25-26 October 201814]
Increase political commitment (e.g. through policy making and key decision makers), where changes in
policy often result in cost-efficient solutions within the HIV epidemic;
Focus on prevention of HIV transmission especially within key populations and others most-at-risk;
Allocate state and international donor funds efficiently in addition to increasing state financial contributions;
Dr Masoud Dara (WHO Regional Office for Europe) emphasized the need to improving efficiencies and efficacy of
HIV response on: Prevention, Testing, Treatment, and Programmatic Performance & Evaluation.
Prevention is the key to an effective HIV response and in many countries in eastern Europe and central Asia there
is a need to offer scaled-up preventive services15 which includes a combination prevention approach
tailored to the needs of the local epidemiological context(s).
Testing is the required to ensure timely diagnosis and treatment initiation, and hence to avoid excess
morbidity and mortality due to TB, AIDS, and other co-morbidities. Half of people in the WHO
European Region (51%) are diagnosed late and this is a challenge in all parts of the Region (West,
Centre, and East)16. The five C’s recommended by WHO should guide all testing efforts: consent,
confidentiality, counselling, correct test results, and connection (e.g. linkage to care). Testing
services should also be: accessible, affordable, and acceptable. Scale-up of HIV self-testing,
community-based testing and low-threshold HIV testing sites offered by lay providers is an urgent
need in the Region.
Treatment is recommended by WHO since 2015 for all people diagnosed with HIV regardless of CD4 count or
stage of infection. An impressive 80% of Member States of the WHO European Region have adopted
this policy. Differentiated care models suitable to the national context (e.g. decentralised ART
provision through services like mobile units) which are integrated to manage co-infections and
strongly link patients to care are urgently requested to Member States by WHO.
Programme
Performance includes high quality: (1) Strategic Information, (2) Intervention Design, (3) Implementation, and (4)
Monitoring & Evaluation. Recognising the complex, local, national, and regional context of
generating evidence and a fully informed HIV response that engages all sectors, WHO revises its
guidelines every 2-3 years to provide updated recommendations. Moreover, a human approach
recognising the dignity of all persons and need to address and remove stigma from the HIV
conversation is paramount to ensure AIDS is no longer a public health threat by 2030. As one
example, WHO no longer classifies gender incongruence (e.g transgender persons) as a mental
14
http://www.who.int/primary-health/conference-phc/en/
15
Including but not limited to: rasied public awareness, sexual and reproductive health and rights, behavioural change interventions, condom
distribution programmes, harm reduction for people who inject drugs like opioid substitution therapy (OST) and needle and syringe programmes
(NSP), treatment as prevention (TasP), pre-exposure prophylaxis (PrEP), and post-exposure prophylactic treatment (PEP).
16
The grouping of countries into the West (23 countries), Centre (15 countries) and East (15 countries) of the WHO European Region is based on
epidemiological considerations and follows the division of countries used in the joint ECDC/WHO HIV/AIDS surveillance in Europe reports. See the
2017 report for details.
illness17, underscoring the need to work with this marginalised group by increasing access to
prevention and care through a non-discriminatory and inclusive public health approach. WHO has
been leading an interagency effort in Europe and central Asia to finalize a UN “common position
paper”. This paper – the first of its kind – provides a platform for catalysing multisectoral efforts, and
commits all 14 participating UN agencies to work together to help end AIDS, Tuberculosis and viral
Hepatitis.
Ms. Yana Panfilova (Founder of Eurasian Union, Person living with HIV, Youth Teenergizer) turned the attention
on the increasingly vital role of young people and adolescents in responding to the HIV epidemic, which was one of the
most recurring theme(s) throughout the Ministerial dialogue as well as the 22nd International AIDS conference
proceedings. Ms. Panfilova, was born with HIV. In 2017, 68 000 adolescents (aged 15-24 years) were living with HIV
(although statistics among this group are poorly recorded). She founded Teenergizer18 which is the only
youth/adolescent-run programme dealing with HIV in eastern Europe and central Asia in order to focus on adolescents
as both a key population driving solutions in the HIV response and to fully leverage and integrate the adolescent
perspective in HIV programming decisions. The power of youth to move HIV response efforts forward in the Region
both politically and in terms of programme implementation is poorly harnessed.
Two primary barriers to adolescent HIV care are highlighted:
(1) Testing barriers caused by pitfalls of the health system like age restrictions on delivery of HIV test
results and the need for parental consent to access voluntary HIV testing services that are both speedy
and youth-friendly;
(2) Poor quality sexual and reproductive health and rights (SRHR) education within school curriculums,
including quality HIV education;
Many adolescents who are living with HIV lost parents or guardians to AIDS, underscoring the need for mental
healthcare and psychosocial support to sustain adherence to ART and improve quality of life among this population.
Ministerial Panel Discussion
During this session, ten Ministers and deputy Ministers/State Secretary in a half round panel, and in alphabetic order,
presented official speeches and country progress, challenges and plans to scale up HIV response. In order to follow the
nature of the meeting which aimed at a free dialogue, in agreement with the co-organizer, this report does not present
each country’s interventions but provide a summary of interventions across the panellists. The panel discussion is
summarized along the five strategic directions of the Action plan for the health sector response to HIV in the WHO
European Region19 and good HIV practices presented by the ten Ministers in attendance under each direction.
Ministerial Panel Delegation
Armenia, Minister of Health Dr Arsen Torosyan
Belarus, The Deputy Minister of Health Dr Dimitri Pinevich
Georgia, The Minister of Labour, Health and Social Affairs Dr David Sergeenko
Kazakhstan, Vice Minister of Health Mr Olzhas Abishev
Latvia, Deputy State Secretary on Health Policy Issues, Ministry of Health Ms Daina Murmane-Umbraško
Lithuania, Vice Minister of Health, Ministry of Health Mr Algirdas Šešelgis
Republic of Moldova, State Secretary, Ministry of Health Dr Rodica Scutelnic
Russian Federation, Deputy Minister of Health Dr Oleg Salagay
17
On June 18 2018, WHO released the new International Classification of Diseases (ICD-11) which classifies gender incongruence as a sexual health
condition rather than mental illness.
18
http://teenergizer.org/
19
Action plan for the health sector response to HIV in the WHO European Region
Tajikistan, The Minister of Health Dr Nasim Hoja Olimzoda
Ukraine, The Acting Minister of Health Dr Ulana Suprun
Strategic Direction 1 Information for Focused Action
Improvement of granular20 HIV surveillance systems, including collection and monitoring of population-based
data in addition to strengthened or well-functioning routine HIV surveillance systems, is a high priority in the
Region. One Member State reports designing a new system for 2019 implementation, some have already
begun to optimise reporting, and but others need to scale-up solutions in this area. Integrating monitoring
systems for co-infections like Tuberculosis, Hepatitis, and STIs (in order of frequency mentioned) was a key
theme highlighted by all meeting participants and Ministers. Three countries in particular report strong
integrated HIV surveillance systems. However, existing challenges mentioned by health authorities included
systems which do not preserve the anonymity of HIV patients (potentially interrupting adherence) and vertical
silo-based and fragmented services in the health systems lacking interlinked databases which may only be
accessible by disease specialists.
All participants recognised the HIV epidemic is concentrated among key populations in their settings and
hence need to focus the work on them, while raising awareness among general population and ensuring access
to quality care for all. Few Ministers additionally acknowledged all relevant key populations, especially with
regard to men who have sex with men (MSM) and people who inject drugs. The three Member States who
acknowledged all relevant key populations (including MSM) also highlighted robust HIV surveillance with
integrated co-morbidity reporting.
HIV among migrants (especially labour migrants) was a commonly reported challenge in the Region. Three
countries have created a bi-lateral agreement and strategy to control TB among the migrant population. A
similar effort by the same three countries is being planned for HIV. Similarly, The Interparliamentary
Assembly of the Commonwealth of Independent States (CIS)21 is also considering cross-border initiatives to
deliver care and treatment to the HIV positive labour migrant population.
Strategic Direction 2 Interventions for Impact
Many participants highlighted the successful beginning of an era of prevention programmes in the EECA
countries of the WHO European Region, including a growing number of countries which are financing opioid
substitution therapy (OST) and/or needle and syringe exchange programmes (NSP) through their state budgets
or national health insurance bodies. Most countries present have functioning harm reduction programmes with
OST and/or NSP in place.
Although pre-exposure prophylaxis (PrEP) has been recommended by WHO since 2015, only one country
mentioned having started a pilot-project by providing PrEP to men who have sex with men at high risk for
sexual acquisition of HIV infection. PrEP is a highly effective and WHO recommends that people at
substantial risk of HIV infection should be offered PrEP as an additional prevention choice, as part of
comprehensive combination prevention. Discussions regarding PrEP and post-exposure prophylactic treatment
(PEP), including the intentions for implementation and scale-up for those at substantial risk of HIV may
benefit this part of the Region. Active training programmes for human resources for health strengthening
within HIV are taking place in some countries in the Region. Sexuality education on the primary education
level and within curriculum design was not discussed although highlighted as a key issue by Ms Yana
Panfilova.
20
Data which are disaggregated by sex, age, population, location etc.
21
At present, the CIS unites: Azerbaijan, Armenia, Belarus, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation, Tajikistan,
Turkmenistan, Uzbekistan and Ukraine (as of 7 August 2018).
Three Member States have received WHO certification of elimination of mother-to-child transmission
(EMTCT) of HIV and/or syphilis and others may soon qualify for the same milestone. Seven out of ten
Ministers present noted continuously working on their elimination programmes. Prevention activities for
mother-to-child transmission of syphilis were not mentioned. More than half of the Ministerial delegation
discussed the role their countries are taking in decentralising services for HIV-testing, counselling, and
treatment including through the use of mobile and stationary units and use of CSOs for social contracting of
services in the HIV response. All meeting participants recognised and confirmed the vital importance of CSOs
in the implementation of HIV programmes and many countries in the Region are working to fully engage this
sector. Just under half of Ministers reported rapid HIV testing availability and HIV self-testing in their
countries. Two countries in particular have excelled in their implementation of both rapid and self-testing on
country-wide scales. Testing of key populations is facilitated through decentralisation of the response, while
few countries mention designing tailored strategies in order to test these populations.
“Treat all” policies are present in many countries, but implementation level and scale vary considerably
among them. Official reports from the countries to WHO and UNAIDS mention adoption of these policies in
national HIV plans during the last two years.
Strategic Direction 3 Delivering for Equity
All key populations in the HIV response need to be considered for all programmes. Interventions focused on
HIV prevention and care in MSM, sex workers, and others were only mentioned by few Ministers. The
majority of countries in the meeting operate under universal health coverage models which prioritise primary
care and prevention, but this is contradicted by relatively few “treat all” policies, some of which are only
partially implemented.
The need to remove legislation that stigmatises both certain populations and criminalises certain actions, such
as sex work or injecting drug use/possession of illicit substances was highlighted by key partners (see
Roundtable Discussion below) as one of the most cost-efficient solutions in the HIV response. Ministerial
leadership plays and invaluable role in creating stigma-free societies while also benefiting from more active
involvement partnerships with communities of key populations and people living with HIV once stigma
dissipates. The following active efforts are being used to help reduce HIV stigma in the Region: removing
travel bans/ restrictions for people living with HIV, removing mandatory HIV testing, signing agreements
between Ministries of Health and groups/ associations of people living with HIV to implement programmes,
and media campaigning to educate and assist youth/ adolescents. One example of a strong partnership through
stigma reduction was partnering with cured hepatitis C (HCV) patients who have since become leaders of
change within the country to reduce stigma within the HIV response. Although these examples were cited,
some countries mentioned the need to reduce stigma but did not discuss active ways to do so. Following
arguments for cost-effectiveness, additional studies to determine stigma reduction activities and stigma
reduction strategies will benefit from scale-up in the Region.
Strategic Direction 4 Financing for Sustainability
Most countries present substantially increased state budgets in order to fund the HIV response in attempts to
reduce the percentage of international donor-based funding and some, although few, no longer require
GFATM funding. Progress towards eliminating out-of-pocket expenses for people living with HIV (e.g price
reductions in ARV medicines, manufacturing ARVs within the country, or adjusting procurement
mechanisms) were the most frequent examples of successfully implementing financially sustainable
interventions. Three Member States explicitly noted the need for continued funding from international donors
like the GFATM in their presentations. Requests for continued international funding were typically in relation
to providing prevention, testing, treatment, and care to migrant populations in the countries.
In summary, countries in the Region are successfully increasing state contributions to progress towards
replacing the need for international funding. All health authorities present in the meeting assured commitment
in this direction. However, cost-efficient solutions as opposed to simply raising the state contribution as a
crucial intervention are essential. For example, some reported conducting studies in their countries to
determine what percentage of the state budget should be reserved social contracting via CSOs to stay on track
in the HIV response. Similar exploration of cost-efficient tools to sustainably finance the HIV response are
encouraged, such as: tools which monitor health expenditure, advocacy work for sustainable financing,
adjustment of pricing policies to leverage cost reductions, or adopting the WHO Health Accounts Country
Platform Approach22.
Strategic Direction 5 Innovation for Acceleration
In coordination with the Action plan for the health sector response to HIV in the WHO European Region,
innovative approaches to the HIV response may include: innovative service delivery models to reach key
populations, unique partnerships for collaboration, technology, financing, or research to optimise impact and
promote innovation. Strong innovations cited in EECA countries by health authorities were changing the
pattern of allocating funds in silos and finding ways of improving intersectoral work to integrate care and
funding mechanisms. Social contracting of NGOs for programme implementation including funding of these
initiatives were also noted as key areas for EECA countries. Some countries also mentioned implementation of
country-wide HIV self-testing or most up to date diagnostic methodologies and machines and use them for
HIV, TB and Hepatitis integrated services.
Regarding innovative financing options, adjustment of policies related to financing in the EECA countries may
yield the cheapest, fastest, and most effective turnovers in responding to HIV half of countries present
specifically cited their work in this area. In terms of innovations and major change, financing mechanisms
appear to be the cornerstone of this strategic direction for the EECA part of the WHO European Region.
Roundtable Discussion- Key Partners
Ms Ganna Dovbakh (Eurasian Harm Reduction Association) commended the strong uptake of harm reduction
programmes in the Region. However, she re-emphasized the need to address all key populations in the HIV response
and de-criminalise activities, like sex work. She reiterated MSM were only referenced as a key population by only three
out of ten countries and was one of the only during the meeting to cite transgender people. If these key populations are
stigmatised and/or criminalised, they will reject services even if comprehensive packages including prevention, testing,
and treatment are in place. Adjusting legislation to be inclusive is the most cost-effective way to respond to HIV.
Ms. Dovbakh provided the example of several countries, where it costs less to de-criminalise possession/use of drugs to
country than it does to house another inmate in the penitentiary system. Around half of inmates in some countries are
incarcerated for possession/use of illicit drugs, but one year in prison costs the system 3-4 times more than providing
comprehensive harm reduction service package and unemployment benefits. Decriminalising possession of illicit
drugs saves money, removes people from prisons, and allows them to work and contribute towards the economy.
Eliminating stigmatising policies, like criminalisation of drug possession/use, does not require additional financial costs
and renders the HIV response more effective.
Mr Wojciech Jerzy Tomczyński (Eastern Europe and Central Asia Union of People Living with HIV) highlighted
treatment for all as the primary aim, especially for all key populations and supported the Ministers drive to scale-up and
fully engage CSOs in the HIV response to reach this goal. However, the reality does not match the road to end AIDS by
2030. He cited only 28% of persons in the Region having access to ARVs as the Regional average. Echoing Ms. Yana
Panfilova, young people were referred to as the future leaders of countries and should be fully engaged. He referenced
the speech from the Acting Minister of Health of Ukraine, who highlighted additional gaps to ensure to treatment for all
is possible and uninterrupted. Comparison of ARV treatment rates in the EECA countries to highlight any differences
between having access and receiving treatment is suggested.
Mr John F. Ryan (The European Commission (EC) Representative of DG Sante) noted the European Commission
recently wrote a “Commission Staff Working Document on Combatting HIV/AIDS, viral hepatitis and tuberculosis in
the European Union and neighbouring countries - State of play, policy instruments and good practices”23 since these
22
WHO Health Accounts Country Platform Approach
23
https://ec.europa.eu/health/sites/health/files/communicable_diseases/docs/swd_2018_387_en.pdf , accessed 14 August 2018).
diseases pose the greatest risk to key populations and the most marginalised groups in the EU. Although there is no ‘one
size fits all’ approach, collecting and evaluating the existing science and literature is an asset when preparing grant
applications, understanding implementation scope, and building bridges. Following Dr Masoud Dara’s lead, prevention
was highlighted by Mr Ryan as the EU supports diagnosis/testing and decentralised responses for key populations, and
ensuring the continuum of care from testing, to follow up, linkage to care and retention especially for all key
populations. Echoing Ms Dovbakh, Mr Ryan also recommends adjusting legislation & regulations to improve access to
care for the most vulnerable groups as a cost-efficient solution.
Mobile populations (e.g refugees, migrants, prisoners, homeless people, among others) have the most pronounced
difficulty within the HIV prevention and care continuum and become vulnerable to this HIV infection, especially after
arrival in the European Region. Mr Ryan referenced the excellent work of Council of Europe for setting high standards
of the entire European Region in improving access to high quality prevention, particularly within the area of prison
health. To support countries, the European Commission hosts a regular policy dialogue, a think tank for all technical
disease areas, and the EU Civil Society Forum which is also open to non-EU Member States, for which membership is
encouraged. The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency
(EMA) have invested in developing technical evidence-based guidance to help develop national strategies and provide a
regional perspective to compliment global recommendations issued by the WHO, including opportunities for country
visits. The European Commission also has a financial instrument for pre-accession assistance to support reforms with
financial and technical assistance. The EU Commission supported the GFATM since 2002, but has the European
Structural Funds available for transition funding. Mr Ryan notes the health programme and research programme, which
has funded 1 billion EURO per year, to focus on these three areas.
Dr Marijke Wijnroks (The Global Fund to Fight AIDS, Tuberculosis and Malaria) confirmed other partners’
requests to focus more intensely on all key populations and need to integrate all technical areas. It seems countries
address the epidemic they would like to have rather than the epidemic they do, which requires acknowledging all key
populations and ensuring high quality surveillance systems to measure the epidemic among them exist. Treatment
outcomes have been surprisingly low as compared to the high financial investment to address key populations and
engage CSOs for social contracting of programme implementation including harm reduction for key populations. Dr
Zsuzsanna Jakab who highlighted this when presenting the second 90 concerning treatment being the most off-track of
the 90-90-90’s in the Region and Mr Vinay Saldanha who noted efficient spending and stigma reduction through strong
leadership needs to be continually exercised to reach these targets. The legal barriers which exist in countries and limit
access to care need to be identified, including procurement systems and mechanisms to deliver the medicines and care
which are vital to care delivery. Some countries in the Region have successfully covered harm reduction services, like
OST and CSOs have an increased role for implementation in a number of countries, but actions fall short of reaching
2020 targets. The GFATM is optimistic the epidemic can be stopped, but the window is closing fast.
Dr Lucica Ditiu (Stop TB Partnership) reminded that the WHO European Region has the highest rates of multidrug
resistant tuberculosis (MDR-TB) She highlighted 19% of the new cases of TB in the Region are either MDR or
rifampicin resistant and 55% of previously untreated TB cases are MDR-TB. About one third of those persons with
MDR-TB are missed and continue transmitting the disease to the general population. There is a need to perform drug
susceptibility tests and harness timely data referencing the impressive expansion of the number of HIV tests reported by
a country in the panel. There is also a need to focus on the quality of procurement systems because lack of quality in
these systems contributes to development of antimicrobial resistance. In regard to advancing the TB agenda and hitting
the 2020 targets, Ms. Ditiu advocated for Minister of Health of countries in the WHO European Region to attend the
UN High-Level Meeting (UNHLM) on TB at the UN Headquarters in New York, New York on 26 September 2018.
Mr Ian McFarlane (UNFPA) requested members of the delegation to focus on three primary areas; (1) prevention-
noting several countries employ very strong prevention approaches which preserves financial resources; (2) integration
of technical areas, health systems and data surveillance/ reporting mechanisms is crucial to respond to the needs of
individuals, and; (3) engagement of both CSOs, all key populations, and youth in the response to HIV on the country-
level. He supported Ms. Yana Panfilova in that the youth are the leaders of tomorrow and their efforts should be
embraced fully and in meaningful ways. UNFPA plans to continually support these works wherever possible.
Ms Nina Ferencic (UNICEF) confirmed previous comments regarding the Regional successes within prevention of
mother-to-child transmission. Maternal and child health services became fully integrated in the Region, providing
evidence that continued integration of technical areas is achievable in the Region. However, to fully eliminate MTCT, it
is necessary to work on:
(1) Prevention: including removing age restrictions and barriers for HIV testing, notification of results, and related
issues; (2) Quality of Care: including optimization of treatment regiments, procurement, and early infant diagnosis, and;
(3) Gender and Human Rights Issues: including women’s sexual and reproductive health rights strengthening and
supporting healthcare delivery and quality education of the adolescent and youth population.
In alignment with Ms. Yana Panfilova’s introductory remarks, quality of HIV and sexual health and reproductive rights
and education is extremely low in the EECA countries. As a result, the youth population turns to the internet for
educational purposes. Within all of the countries, adolescent services is missing despite a wide array of health sector
reforms. These should be strengthened moving forward.
Concluding Remarks
During her closing remarks, Dr Zsuzsanna Jakab expressed full confidence that with sustained implementation of
evidence-based approaches to prevention, testing, treatment and care, the number of new HIV infections will decrease
and the quality of life for people living with HIV would improve. Promising trends in several countries of our Region
are already being observed. To continue progress, ensuring inclusive planning through a whole-of-government and
whole-of-society approach, destigmatizing HIV and people affected by HIV, prioritizing the needs of all key
populations, removing legal barriers and providing services are accessible and fully financed responses is paramount.
During the 69th Regional Committee for Europe in September 2019, the mid-term progress in implementing the Action
plan for the Health Sector Response to HIV in WHO European Region will be reviewed. The Ministerial policy
dialogue hosted by the Government of the Netherlands today allowed participants to reflect on the progress, exchange
good practices, and provide peer to peer support to countries and partners. Moving forward, Dr Jakab assures the 2020
and 2030 targets will be achieved by closely examining the achievements and the gaps which need to be addressed to
leave no one behind.
Next Steps: WHO and Partners
⇒ Mid-term progress report for the Action plan for the health sector response to HIV in the WHO European
Region’s implementation will be prepared and presented at 69th Regional Committee for Europe, September
2019;
⇒ Develop roadmaps for Action plan implementation solutions for countries and partners in the EECA part of the
Region from now until 2020, to close gaps in prevention, testing, treatment, and care;
⇒ Ensure ongoing policy dialogue to move faster towards the 90-90-90 targets;
⇒ Disseminate widely the just launched Compendium of good practices in the health sector response to HIV in
the WHO European Region (English and Russian) and prepare an online repository of future good practices;
⇒ To plan regular/annual meetings with the Ministers to review the progress;
⇒ During 2018, the 40th various meetings require participation of Governments, Agencies and Key Partners
including: the anniversary of the Alma-Ata Declaration on Primary Health Care, the first ever UN General
Assembly High-level Meeting on Ending Tuberculosis, and the third UN General Assembly High-level
Meeting on Noncommunicable Diseases; in this regard, Heads of State are encouraged to attend these
meetings;
Next Steps: Member States
⇒ Continued adoption of “treat all” policies to initiate treatment for all those diagnosed with HIV, as soon as
possible after diagnosis and regardless of CD4 count;
⇒ Continue strengthen efforts on improving linkages to care, seeking more intersectoral cooperation to better
prevent and timely treat co infections and co-morbidities and optimise funding for an integrated care and
people centred approach
⇒ Fully engage youth and adolescents in the response to HIV as is being done with CSOs;
⇒ Continue to integrate innovative testing and prevention efforts within the standard HIV package offered
through the local health system, including oral PrEP (containing tenofovir) as recommended by WHO since
2015, HIV self-testing, community-based testing, assisted partner notification, among other strategies:
⇒ Continue to decentralise ART provision through services like mobile units which are integrated to manage co-
infections, strongly link patients to care, and leverage lay personnel for delivery and care;